Gastroenterology
The findings suggest that Dau-d4 can supplement current DPP4 treatment approaches for type 2 diabetes.
The findings of a recent study may help identify targets for the prevention or treatment of rheumatoid arthritis and other inflammatory conditions.
The findings of a recent study suggest that microbial consortia such as MET-2 may be effective strategies to keep intestinal pathogens and antibiotic-resistant organisms at bay.
The findings of a recent study suggest that even mild cases of COVID-19 can disrupt the gut microbiota.
The findings of a recent study provide insights into how industrialized lifestyles have influenced the composition of the human gut microbiota.
The findings of a recent study may help researchers to characterize the composition of the human gut microbiota in health and disease.
The findings of a recent study suggest that FMT is an effective strategy to mitigate the intestinal side effects of cancer immunotherapy.
Understanding how gut microbes are linked to preclinical Alzheimer’s disease could help to identify markers of disease risk.
A recent review highlights that changes in fear-related mental health conditions are observed when the gut microbiota is altered or removed.
Osnat Tirosh, Head of Microbiome Research & Innovation at Biomica, talks about the validation of the mechanism of action of BMC333 consortia through pre-clinical studies in IBD models.
